Guide5 min readFacts checked 26 September 2026
Does injection site matter for GLP-1 shots?
For the amount of medicine that reaches your blood, the site makes little difference. The labels for semaglutide and tirzepatide say the belly, thigh and upper arm give similar levels. One study tested this for tirzepatide. It found almost the same total amount from all three sites, and a slightly lower peak after thigh and arm shots. We found no study that compared the left and right side.
Claritide keeps a body map of your shots and tells you when a spot is still resting.
Where do the labels say to inject?
The US labels for weekly semaglutide and tirzepatide shots name three areas: the belly (abdomen), the thigh and the upper arm. The tirzepatide labels add that the back of the upper arm is for another person to inject.
The labels also say to rotate: use a different spot with each weekly shot. The same area is fine, as long as the spot changes. One semaglutide label adds that the time of day and the injection site can change without any change to the dose.
What did the tirzepatide injection-site study find?
Eli Lilly ran a study to answer this question, registered as NCT04050670. Fifty-four healthy adults of many body sizes took part. Each had one 5 mg shot of tirzepatide in the belly, one in the thigh and one in the upper arm. The shots were at least 35 days apart. Their blood was sampled for 20 days after each shot. The results were posted on ClinicalTrials.gov in 2023.
- Total amount in the blood over time: the upper arm gave 99% of the belly's amount, and the thigh 95%.
- Highest level: about 8% lower after an upper arm shot than after a belly shot. About 14% lower after a thigh shot.
All of these fell inside the 80 to 125% range the study set in advance. The tirzepatide labels sum it up as similar exposure in the belly, thigh and upper arm. A later analysis by Lilly scientists says the same.
| Site | Total in the blood | Highest level |
|---|---|---|
| Belly | 100% | 100% |
| Upper arm | 99% | 92% |
| Thigh | 95% | 86% |
Does the site change side effects?
The study also listed side effects after each shot. Nausea was reported by 20 of 54 people after the belly shot. After the arm it was 12 of 54, and after the thigh 11 of 53. Less appetite showed a similar split.
The study was not built to compare side effects. One shot in healthy volunteers is also not the same as weeks of use. So it does not show that one site is gentler. We found no study that has tested appetite or side effects by site over weeks of shots.
Can I rotate on the same side of my stomach?
Yes. The tirzepatide medication guide says you may use the same area of your body. Just choose a different spot each time. What matters is not using the exact same spot again and again.
Rotation protects your skin. The tirzepatide vial instructions say changing the spot lowers the risk of pitted or thickened skin, and of lumps under the skin. They also say not to inject into skin that is pitted, thickened, lumpy, tender, bruised, scaly, hard or scarred.
People keep track in simple ways. A note on the phone works, or "L R L R" on the pen cap, or a paper map on the fridge. Claritide has a body map: tap where each shot went, and it tells you when a spot is still resting.
Why does my log show a left or right difference?
If you switch sides each week, every other week is a "left" week, and weeks differ for many reasons. Day-to-day weight moves mostly with water. A late shot, a dose step or a big weekend can change a week too. Two sets of weeks like that can look different by chance.
A fair test would need many weeks on each side, with everything else held steady. That is hard to do at home. We found no study that compared the left and right side. The three-site study is the closest evidence, and it found almost the same total amount from the belly, thigh and upper arm.
What about redness, lumps and bruises?
Mild redness or soreness where the needle went in is common, and it usually fades within hours. Injection site reactions are on the list of common side effects in the tirzepatide weight-reduction label.
Redness that spreads or does not go away is a reason to call your healthcare provider. Signs of a serious allergic reaction, such as swelling of the face or throat or trouble breathing, need medical help right away.
Questions people ask
Does injection site matter for tirzepatide?
For how much reaches your blood, very little. The label says exposure is similar in the belly, thigh and upper arm. The injection-site study found almost the same total amount from all three, with a slightly lower peak from the thigh and arm.
Does injection site matter for semaglutide?
The semaglutide labels say exposure is similar in the belly, thigh and upper arm. One label adds that the injection site can change without any change to the dose.
Is one injection site better for appetite?
We found no study that tested appetite by site over weeks of shots. The labels treat the belly, thigh and upper arm as equal choices.
How long do injection site reactions last?
Mild redness or soreness usually fades within hours. If redness spreads or does not go away, call your healthcare provider.
Sources
Every fact above comes from one of these, checked on 26 September 2026.
- Zepbound® (tirzepatide) for weight reduction and sleep apnea: US prescribing information, medication guide and instructions for use (Eli Lilly, revised August 2026), DailyMeddailymed.nlm.nih.gov · read 26 September 2026
- Mounjaro® (tirzepatide) for type 2 diabetes: US prescribing information (Eli Lilly, DailyMed version of August 2026)dailymed.nlm.nih.gov · read 26 September 2026
- Wegovy® (semaglutide) injection and tablets for weight reduction: US prescribing information and medication guide (Novo Nordisk, revised June 2026), DailyMeddailymed.nlm.nih.gov · read 26 September 2026
- Ozempic® (semaglutide) for type 2 diabetes: US prescribing information (Novo Nordisk, DailyMed version of June 2026)dailymed.nlm.nih.gov · read 26 September 2026
- ClinicalTrials.gov NCT04050670: effect of injection site on the relative bioavailability of a single dose of tirzepatide (results posted 24 March 2023)clinicaltrials.gov · read 26 September 2026
- Schneck and Urva, Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide, CPT Pharmacometrics & Systems Pharmacology, 2024 (PMC10962491)pmc.ncbi.nlm.nih.gov · read 26 September 2026
- Claritide lesson: Tracking what mattersclaritide.app · read 26 September 2026
- Claritide lesson: The injection itselfclaritide.app · read 26 September 2026
- What people describe: "I write LRLR on the pen cap in sharpie", r/GLP1Discussion, 16 September 2026reddit.com · read 26 September 2026
Every shot, every site and every rest day, kept for you: Claritide for iPhone.